Literature DB >> 34627

Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas.

E Samols, G C Weir.   

Abstract

The effects of adrenergic substances on pancreatic insular secretions were studied in a completely isolated canine pancreas with exclusion of the duodenum from the perfusion circuit. To ensure adequate blockade, blockers were infused before agonists. A dose range of beta-receptor blockade was tested, and putative alpha-adrenergic effects were confirmed by combined alpha- and beta-adrenergic receptor blockade.beta-Adrenergic agonism (2 ng/ml isoproterenol) induced a mean integrated increase of 79+/-20% in somatostatin secretion, whereas glucagon and insulin secretion were increased by 185+/-45 and 495+/-146%, respectively. The stimulations of D, A, and B cells were abolished by propranolol.alpha-Adrenergic agonism (10 ng/ml epinephrine) after beta-adrenergic blockade) moderately decreased somatostatin (-37+/-7%) secretion, moderately increased glucagon (91+/-19%), and markedly decreased insulin (-85+/-3%) release. Similar effects on D-, A-, and B-cell secretion were induced with 2 ng/ml epinephrine or 10 ng/ml norepinephrine after beta-adrenergic blockade. The alpha-adrenergic effects on the D and A cell were abolished by either phentolamine or by phenoxybenzamine. This study showed that there are indeed alpha-adrenergic receptors on A cells and that the secretion of glucagon, a "stress" hormone, was stimulated either by alpha- or beta-adrenergic receptor agonism. D-cell secretion, like that of the B cell, was inhibited by alpha-adrenergic agonism and was stimulated by beta-adrenergic agonism. However, beta-adrenergic-induced changes in D-cell secretion were smaller in magnitude than those of B-cell secretion.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 34627      PMCID: PMC371944          DOI: 10.1172/JCI109294

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

Review 1.  Neural control of the endocrine pancreas.

Authors:  S C Woods; D Porte
Journal:  Physiol Rev       Date:  1974-07       Impact factor: 37.312

2.  Pharmacological characteristics of adrenergic receptors.

Authors:  R F Furchgott
Journal:  Fed Proc       Date:  1970 Jul-Aug

3.  Adrenergic modulation of pancreatic glucagon secretion in man.

Authors:  J E Gerich; M Langlois; C Noacco; V Schneider; P H Forsham
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

4.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

5.  Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas.

Authors:  J Iversen; D W Miles
Journal:  Diabetes       Date:  1971-01       Impact factor: 9.461

6.  The pharmacological differentiation of adrenergic receptors.

Authors:  R F Furchgott
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

7.  Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells.

Authors:  J M Polak; A G Pearse; L Grimelius; S R Bloom
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

8.  Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas.

Authors:  J Iversen
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

9.  The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.

Authors:  R M Walter; R J Dudl; J P Palmer; J W Ensinck
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

10.  Glucose modulation of amino acid-induced glucagon and insulin release in the isolated perfused rat pancreas.

Authors:  A S Pagliara; S N Stillings; B Hover; D M Martin; F M Matschinsky
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

View more
  37 in total

Review 1.  Glucoregulation during exercise : the role of the neuroendocrine system.

Authors:  Robert H Coker; Michael Kjaer
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

2.  The effects of epinephrine on islet hormone secretion in the dog.

Authors:  B Ahrén; R C Veith; G J Taborsky
Journal:  Int J Pancreatol       Date:  1988-07

Review 3.  Neural regulation of the endocrine pancreas.

Authors:  F C Brunicardi; D M Shavelle; D K Andersen
Journal:  Int J Pancreatol       Date:  1995-12

4.  Autonomic regulation of postprandial plasma somatostatin, gastrin, and insulin.

Authors:  M R Lucey; J A Wass; P Fairclough; J Webb; S Webb; S Medbak; L H Rees
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

5.  In situ binding of islet hormones in the isolated perfused rat pancreas: evidence for local high concentrations of islet hormones via the islet-acinar axis.

Authors:  A Nakagawa; J I Stagner; E Samols
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  Pancreatic somatostatin secretion is suppressed by splanchnic nerve stimulation.

Authors:  M W Roy; M S Jones; R E Miller
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

7.  Interactions between autonomic nerves and endocrine cells of the gastroenteropancreatic system.

Authors:  P H Smith; Katherine L Madson
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

Review 8.  Interactions between the central nervous system and pancreatic islet secretions: a historical perspective.

Authors:  Denovan P Begg; Stephen C Woods
Journal:  Adv Physiol Educ       Date:  2013-03       Impact factor: 2.288

9.  Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level.

Authors:  J L Leahy; G C Weir
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

10.  Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.

Authors:  G J Taborsky; J W Ensinck
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.